The U.S. Centers for Disease Control and Prevention (CDC) has selected ICF (NASDAQ:ICFI), a consulting and technology services provider to government and commercial clients around the world, for three contracts with a combined value of up to $44.5 million. The contracts, awarded in the third quarter, will expand ICF’s role as a leader in technology, surveillance and health analytics.
“ICF has long-standing history of supporting CDC’s mission through our survey, research and health analytics work and the development of IT systems to support these and a wide range of other critical public health needs,” said Barbara Rudin, executive vice president for ICF. “We look forward to expanding our role in supporting health informatics and systems that improve the CDC’s ability to acquire, analyze and distribute data for the benefit of public health.”
The new agreements broaden ICF’s support of the CDC through improved analytic capabilities in research and surveillance, strategic planning, enterprise and data architecture, software engineering and assessment, technical support and management consulting. The contracts include:
Two new multiple award blanket purchase agreements with CDC’s National Center for Health Statistics’ Division of Health Care Statistics. ICF will support CDC’s National Health Care Surveys with survey design and implementation, electronic data collection, processing of administrative data and electronic health records, data storage and warehousing, and data integration including record linkage. The contracts are valued up to $35 million over five years.
- A re-compete health analytics contract with CDC’s Division of HIV/AIDS Prevention to serve as the Data Coordinating Center for its HIV Supplemental Surveillance System. ICF currently provides support, oversight and technical assistance to 43 grantees nationwide funded by CDC in its two largest HIV behavioral surveillance systems: the National HIV Behavioral Surveillance System and the Medical Monitoring Project. ICF ensures that the CDC has high-quality, timely data that are ready for analysis, dissemination and use for program and policy improvement. The contract has a value of $9.5 million and a term of five years, including one base year and four option years.
ICF has been at the center of critical global health issues for nearly 50 years, working with clients in the government, business, nonprofit and academic worlds to improve health outcomes and promote well-being. Informed by this depth of experience, ICF’s pioneering solutions have had a positive and lasting impact on the field, from establishing baseline costs of providing AIDS treatment throughout the developing world to operating two CDC national surveillance systems with real-time reporting of diseases like the flu and Ebola to conducting the National Youth Risk Behavior Survey – the premier instrument for measuring health risk behaviors among high school students.For More Information
ICF (NASDAQ:ICFI) is a global consulting services company with approximately 7,500 full- and part-time employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and the effects of the novel coronavirus disease (COVID-19) and related federal, state and local government actions and reactions on the health of our staff and that of our clients, the continuity of our and our clients' operations, our results of operations and our outlook. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements THAT are included in the "Risk Factors" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.